Semen Analysis Market Expected to Reach $1.49 Billion by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Semen Analysis Market," The semen analysis market was valued at $955.47 million in 2021, and is estimated to reach $1.49 billion by 2031, growing at a CAGR of 4.5% from 2022 to 2031.

A semen analysis refers to the laboratory testing of semen to evaluate male fertility. It can detect male fertility problems and an accurate diagnosis may allow the opportunity to improve natural fertility or select an appropriate treatment. A sperm analysis measures three major aspects of sperm health—the sperm count, the shape of the sperm, and sperm motility. According to the American Association for Clinical Chemistry (AACC), the tests should be performed at least seven days apart and over the course of two to three months. Sperm counts can fluctuate on a daily basis. 

The COVID-19 pandemic negatively impacted the global semen analysis industry initially in 2020 due to global economic recession led by COVID-19. However, the market is anticipated to witness recovery in 2021, and witness stable growth for semen analysis in the coming future.

One of the major factors driving the growth of the semen analysis market size include upsurge in the incidences of infertility among males within the population globally. In addition, innovation and advancement in male fertility testing and rise in awareness regarding male fertility testing are some semen analysis market trends further expected to boost the semen analysis market growth during the forecast period. However, lack of awareness in developing countries is likely to hamper the growth of the semen analysis market during the forecast period. Conversely, growth potential of emerging economies and sales of male fertility testing kits on online platform is expected to provide numerous semen analysis market opportunity for growth during the forecast period.

The semen analysis market is segmented on the basis of product, age group, end user, and region. By product, the market is segmented into semen analyzers, centrifuges for sample preparation, semen test kits, disposables & consumables, and software. The semen analyzer segment is further sub-segmented into manual semen analyzer, and automated semen analyzer. The disposable & consumables segment was the major shareholder 2021, owing to increase in adoption of disposables & consumables during semen analysis testing. However, semen test kits segment registered highest CAGR during forecast period, owing to increase in adoption of semen test kits for home-use due to its reliable quality and easily interpretable results.

By age group, the market is segmented into 34 and below 34 years, 35-40 years, and 41 and greater than 41 years. The 41 and greater than 41 years segment dominated the global semen analysis market share in 2021, and is anticipated to remain dominant during the forecast period. This is attributed to the increase in prevalence of infertility in age between 41 and greater than 41 years. However, 35-40years segment registered highest growth registering CAGR of 4.8% owing to increase in the use of semen analysis tests by men between the ages of 35 and 40 to monitor sperm count and male fertility.

By end user, it is categorized into fertility centers, hospitals, diagnostic laboratories, and others. The others segment is further segmented into research institute, and home care settings. The fertility centers segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period. This is attributed to increase in the number of the infertility rates of the population as well as increase in IVF procedure and vasectomy performed in fertility centers.

By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Asia-Pacific is predicted to dominate the growth of the semen analysis market due to surge in infertility cases and rise in awareness regarding semen analysis testing among the population. For instance, according to article published in Indian Journal of Community Medicine, in 2019, infertility is a significant health condition that affects approximately 8%–10% of couples around the world. Infertility affects 60–80 million couples worldwide each year, with India accounting for approximately a quarter of them. On the other hand, Europe is anticipated to be the second largest market during the analysis period owing to presence of higher number of infertility centers, rise in investment in healthcare, and increase in awareness about the healthcare technologies among Europeans.

KEY FINDINGS OF THE STUDY 
• On the basis of product, the disposables & consumables segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
• On the basis of age group, the 41 and greater than 41 years segment dominated the market in 2021, and is expected to continue this trend during the forecast period.
• On the basis of end user, fertility clinics segment is projected to grow at a CAGR of 4.7% during the forecast period.
• On the basis of region, Asia-Pacific is expected to experience growth at the highest rate, registering a CAGR of 4.6% during the forecast period.